They discovered that CST6, which is secreted by MM cells, inhibits the development of osteolytic diseases and other diseases that may be related to osteoclast-mediated bone flow in MM by blocking osteoclast differentiation [16]. This evidence concerns the gene CST6 and Miyoshi myopathy.